background
rapid
etiolog
diagnosi
respiratori
viru
infect
may
impact
antivir
antibiot
therapi
patient
cohort
predict
clinic
cours
pointofcar
test
detect
respiratori
virus
limit
diagnost
perform
clinic
usabl
novel
multianalyt
pointofcar
antigen
detect
test
system
maripoc
arcdia
intern
oy
ltd
turku
finland
detect
eight
respiratori
virus
influenza
b
virus
respiratori
syncyti
viru
rsv
adenoviru
human
metapneumoviru
parainfluenza
type
virus
singl
nasopharyng
swab
specimen
fulli
autom
randomaccess
immunoassay
method
object
evalu
maripoc
pointofcar
test
system
comparison
revers
transcript
polymeras
chain
reaction
rtpcr
pediatr
emerg
depart
set
studi
design
prospect
collect
sampl
children
mean
age
year
respiratori
symptom
andor
fever
analyz
maripoc
multiplex
rtpcr
result
sensit
specif
confid
interv
maripoc
test
influenza
n
influenza
b
n
rsv
n
adenoviru
n
human
metapneumoviru
n
respect
parainfluenzavirus
detect
five
patient
conclus
novel
pointofcar
test
system
rapid
practic
specif
method
simultan
detect
eight
respiratori
virus
compar
rtpcr
sensit
moder
high
detect
rsv
influenza
virus
low
adenoviru
children
year
age
everi
year
averag
respiratori
tract
infect
acut
respiratori
tract
infect
common
caus
admit
children
hospit
develop
countri
children
respiratori
tract
infect
mainli
viral
etiolog
common
respiratori
virus
includ
influenza
b
virus
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
piv
type
rhinoviru
clinic
import
newli
discov
human
metapneumoviru
hmpv
coronavirus
human
bocaviru
still
partli
understood
respiratori
virus
caus
nonspecif
local
system
symptom
fever
cough
rhiniti
fatigu
headach
make
imposs
clinic
differenti
ill
caus
specif
pathogen
even
influenza
often
consid
typic
clinic
manifest
diagnosi
base
clinic
ground
inaccur
particularli
true
young
children
unabl
express
subject
symptom
etiolog
diagnosi
respiratori
infect
would
need
set
pediatr
emerg
depart
target
antivir
therapi
influenza
prevent
transmiss
virus
hospit
mean
patient
cohort
optim
infect
control
measur
addit
benefit
viral
detect
might
includ
reduct
use
chest
xray
laboratori
investig
avoid
overus
antibiot
better
predict
clinic
cours
polymeras
chain
reaction
pcr
becom
standard
method
respiratori
viral
diagnost
due
high
sensit
good
avail
shorter
delay
result
comparison
convent
method
viral
cultur
multiplex
revers
transcript
rt
pcr
method
allow
detect
sever
virus
time
howev
rtpcr
viral
antigen
detect
perform
laboratori
provid
inform
time
clinic
decis
emerg
depart
pointofcar
poc
test
design
avail
directli
site
patient
care
access
staff
without
laboratori
train
provid
result
quickli
enough
impact
clinic
decisionmak
influenza
b
virus
rsv
poc
test
use
frequent
although
studi
evalu
diagnost
perform
test
provid
vari
result
practic
poc
test
emerg
depart
may
compromis
need
handson
time
perform
test
unclear
visual
result
object
studi
evalu
diagnost
perform
practic
usabl
novel
multianalyt
detect
system
eight
respiratori
virus
maripoc
arcdia
intern
oy
ltd
turku
finland
clinic
ambulatori
care
set
compar
result
rapid
antigen
detect
test
perform
pediatr
emerg
depart
multiplex
rtpcr
test
perform
laboratori
condit
particip
recruit
prospect
januari
march
pediatr
emerg
depart
turku
univers
hospit
turku
finland
depart
serv
children
year
age
patient
elig
compar
studi
maripoc
test
rtpcr
hospit
emerg
depart
respiratori
symptom
cough
rhiniti
wheez
fever
without
focu
treat
outpati
respiratori
infect
suspect
caus
influenza
viru
rsv
adenoviru
suspicion
virus
use
inclus
criterion
earlier
use
poc
test
routin
detect
influenza
b
viru
rsv
adenoviru
influenza
suspect
patient
high
fever
cough
rsv
bronchiol
wheez
ill
adenoviru
nonstreptococc
tonsil
patient
two
visit
emerg
depart
studi
period
includ
studi
first
visit
elig
parent
ask
fill
inquiri
chronic
ill
child
onset
symptom
immun
statu
season
influenza
clinic
data
deriv
medic
record
ethic
committe
hospit
district
southwest
finland
approv
studi
protocol
parent
particip
children
gave
inform
consent
nasopharyng
sampl
collect
use
flock
swab
copan
brescia
itali
nasopharyng
swab
insert
either
nostril
specimen
collect
depth
least
cm
swab
elut
ml
rti
sampl
buffer
arcdia
intern
oy
ltd
turku
finland
insert
maripoc
multianalyt
antigen
detect
test
system
pediatr
emerg
depart
immedi
sampl
emerg
depart
nurs
collect
sampl
train
use
test
system
manufactur
h
train
poc
analysi
remain
sampl
solut
transfer
viru
diagnost
laboratori
depart
virolog
univers
turku
sampl
children
admit
hospit
analyz
immedi
pcr
test
sampl
children
store
c
analyz
case
first
sampl
avail
rtpcr
done
new
sampl
taken
h
first
one
maripoc
multianalyt
test
system
provid
pathogen
specif
result
eight
respiratori
virus
singl
nasopharyng
swab
influenza
b
virus
rsv
ab
adenoviru
hmpv
parainfluenza
type
virus
nasopharyng
sampl
kit
includ
also
test
streptococcu
pneumonia
test
system
also
allow
simultan
detect
adenoviru
group
streptococcu
throat
swab
pneumonia
throat
swab
result
includ
studi
test
fulli
autom
allow
randomaccess
analysi
platform
appli
proprietari
twophoton
fluoresc
excit
detect
techniqu
antigen
detect
immunometr
assay
principl
techniqu
character
microvolum
analysi
separationfre
fluoresc
measur
bioaffin
bind
reaction
nasopharyng
swab
sampl
rti
sampl
buffer
insert
analyz
cap
bar
code
autom
analysi
analyz
dispens
sampl
l
aliquot
parallel
well
test
plate
one
well
per
pathogen
well
contain
reagent
dri
state
test
system
automat
report
screen
userinterfac
preliminari
result
min
final
result
report
h
studi
final
maripoc
result
compar
result
provid
refer
method
except
four
case
maripoc
system
fail
report
final
result
case
preliminari
result
compar
result
refer
method
multiplex
pcr
assay
seeplex
seegen
seoul
korea
use
refer
method
detect
respiratori
virus
influenza
b
virus
rsv
b
adenoviru
hmpv
parainfluenza
type
virus
rhinoviru
ab
coronavirus
cdna
synthesi
perform
use
randomhexam
primer
fermenta
york
uk
multiplex
pcr
assay
perform
accord
manufactur
instruct
sensit
multiplex
pcr
test
influenza
b
viru
sampl
store
c
found
lower
fresh
sampl
therefor
hous
pcr
test
use
refer
method
detect
influenza
b
viru
store
sampl
pcr
perform
describ
earlier
primer
probe
describ
earlier
specimen
contradictori
result
influenza
b
multiplex
inhous
pcr
test
test
also
timeresolv
fluoroimmunoassay
method
gave
accord
result
inhous
pcr
test
data
analyz
descript
method
sensit
specif
posit
neg
predict
valu
confid
interv
calcul
separ
viru
regardless
detect
two
virus
sampl
day
onset
symptom
sampl
compar
subgroup
diabet
mellitu
n
apec
n
oligoarthr
n
pulmonari
diseas
asthma
n
anorexia
nervosa
n
prematur
n
renal
insuffici
n
crohn
diseas
n
ttest
leven
test
equal
varianc
twosid
p
limit
statist
signific
sampl
total
children
test
maripoc
test
system
rtpcr
patient
characterist
list
tabl
median
age
children
year
interquartil
rang
year
sixtynin
patient
admit
hospit
clinic
personnel
emerg
depart
regard
maripoc
test
system
easi
use
point
care
posit
result
avail
alreadi
within
min
patient
final
posit
result
least
one
viru
patient
preliminari
result
report
posit
final
result
neg
median
time
onset
symptom
sampl
day
case
posit
alreadi
preliminari
report
n
vs
day
posit
final
report
n
p
time
onset
symptom
sampl
significantli
longer
children
fals
neg
result
maripoc
compar
children
posit
result
maripoc
pcr
median
vs
day
p
maripoc
rtpcr
done
separ
sampl
case
time
interv
obtain
sampl
less
h
case
h
case
h
case
latter
two
case
rsv
detect
maripoc
rtpcr
time
delay
sampl
therefor
affect
result
case
multiplex
rtpcr
method
seeplex
detect
rhinovirus
coronavirus
includ
maripoc
test
system
maripoc
system
posit
least
virus
sampl
comparison
rtpcr
posit
least
virus
cover
maripoc
least
analyz
virus
sampl
tabl
rtpcr
detect
rhinoviru
coronavirus
children
eleven
sampl
posit
virus
multiplex
rtpcr
sampl
posit
virus
maripoc
none
sampl
posit
virus
sensit
specif
posit
neg
predict
valu
maripoc
system
viru
comparison
rtpcr
shown
tabl
influenza
b
detect
children
rtpcr
also
maripoc
test
system
min
preliminari
report
give
overal
sensit
influenza
thirtyf
children
studi
popul
posit
rsv
rtpcr
maripoc
detect
rsv
patient
sensit
specif
posit
result
report
alreadi
min
maripoc
test
gave
sensit
adenoviru
compar
rtpcr
nine
sampl
neg
adenoviru
maripoc
posit
pcr
six
sampl
doubl
posit
find
multiplexpcr
sampl
adenoviru
found
togeth
rsv
hmpv
rhinoviru
hmpv
detect
patient
rtpcr
also
maripoc
small
number
parainfluenza
viru
find
prevent
evalu
test
diagnost
perform
virus
two
sampl
posit
parainfluenza
type
viru
three
sampl
parainfluenza
type
viru
rtpcr
maripoc
antigen
detect
system
highli
specif
moder
sensit
diagnost
influenza
rsv
infect
children
test
system
sensit
influenza
virus
rsv
specif
higher
test
virus
comparison
rtpcr
test
characterist
satisfactori
clinic
set
rapid
report
result
outweigh
minor
limit
sensit
sinc
avail
effect
neuraminidas
inhibitor
drug
treatment
influenza
need
rapid
influenza
test
ambulatori
clinic
need
highlight
influenza
pandem
offici
instruct
guid
healthcar
provid
use
pcr
test
instead
poc
test
poor
sensit
latter
studi
report
sensit
specif
influenza
poc
test
compar
rtpcr
howev
studi
children
better
sensit
specif
poc
test
influenza
report
may
partli
due
higher
viral
load
children
adult
studi
influenza
poc
test
immunofluoresc
test
viral
cultur
refer
method
instead
sensit
rtpcr
sensit
specif
report
earlier
commerci
avail
poc
test
might
challeng
especi
detect
influenza
b
viru
maripoc
test
perform
well
detect
influenza
b
virus
sensit
influenza
larg
confid
interv
due
low
number
case
yearli
rsv
epidem
major
caus
hospit
children
although
antivir
treatment
avail
benefit
rapid
detect
rsv
demonstr
detect
rsv
perform
maripoc
test
appear
compar
rapid
test
document
sensit
specif
diagnost
yield
maripoc
test
fairli
good
detect
viru
sampl
higher
diagnost
yield
rtpcr
result
better
sensit
detect
rhinovirus
coronavirus
includ
maripoc
system
yield
possibl
also
diagnost
perform
maripoc
test
system
might
differ
anoth
epidemiolog
situat
purpos
conduct
studi
season
influenza
virus
rsv
circul
commun
need
rapid
test
appear
highest
virus
januari
march
pandemictyp
influenza
influenza
b
yamagata
line
domin
strain
influenza
virus
finland
influenza
domin
epidem
januari
influenza
b
februari
march
thu
higher
number
influenza
b
influenza
virus
studi
reflect
epidemiolog
situat
fairli
high
proport
sampl
posit
rsv
studi
accord
epidemiolog
occurr
rsv
winterspr
finland
adenoviru
often
detect
pcr
simultan
anoth
respiratori
viru
possibl
case
adenoviru
innoc
bystand
viru
pathogen
inde
adenoviru
detect
studi
frequent
also
asymptomat
individu
pcr
data
suggest
multiplex
rtpcr
may
set
excess
high
sensit
lead
clinic
irrelev
find
maripoc
test
system
found
easi
incorpor
work
clinic
personnel
emerg
depart
short
handson
time
regard
import
advantag
earlier
use
nonautom
poc
test
posit
case
result
receiv
alreadi
preliminari
report
min
rapid
clear
report
result
autom
archiv
data
consid
import
featur
test
system
user
cost
evalu
studi
suggest
lower
poc
test
system
compar
multiplex
pcr
result
demonstr
maripoc
test
system
provid
new
option
detect
multipl
respiratori
virus
singl
nasopharyng
swab
rapid
userfriendli
way
test
system
high
specif
test
virus
moder
high
sensit
detect
influenza
virus
rsv
clinic
evalu
regard
identif
hmpv
adenoviru
parainfluenza
virus
test
system
need
studi
financi
support
academi
finland
grant
central
finland
central
hospit
found
grant
arcdia
intern
oy
ltd
provid
maripoc
test
system
partial
refer
test
none
declar
ethic
committe
hospit
district
southwest
finland
approv
studi
protocol
parent
particip
children
gave
inform
consent
